|
|
| Attention Investors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Your results on : IPO | IPO Synopsis |
|
|
|
| Sudeep Pharma Ltd |
|
Registered Office:
129/1/A GIDC Estate Nandesari,
,
Vadodara
-
391340
,
Gujarat
, India.
Phone :
+91 265 284 0656/329 1354 Fax:
Email : cs.sudeep@sudeepgroup.com
Website : https://www.sudeeppharma.com
|
Initial public offer of up to [*] equity shares of face value of Re. 1/- each ("Equity Shares") of Sudeep Pharma Limited ("Company") for cash at a price of  [*] per equity share (Including a Share Premium of [*] per Equity Share) ("Offer Price") aggregating up to [*] crores comprising a fresh issue of up to [*] equity shares of face value of Re. 1/- aggregating up to 95.00 crores by the company ("Fresh Issue") and an offer for sale of up to 13,490,726 equity shares of face value of Re. 1/- aggregating up to [*] crores ("Offered Shares") by the selling shareholders, consisting of up to 3,567,670 equity shares of face value of Re. 1/- aggregating up to [*] crores by Sujit Jaysukh Bhayani*, up to 8,418,856 equity shares of face value of Re. 1/- aggregating up to [*] crores by Sujeet Jaysukh Bhayani HUF, up to 750,000 equity shares of face value of Re. 1/- aggregating up to [*] crores by Shanil Sujit Bhayani** and up to 754,200 equity shares of face value of Re.1/- aggregating up to [*] crores by Avani Sujit Bhayani** (Collectively "the Selling Shareholders") and such equity shares offered by the selling shareholders ("Offer for Sale", and together with the fresh issue, the "Offer").
The company, in consultation with the brlms, may consider an issue of specified securities aggregating up to 19.00 crores, as may be permitted under applicable law, prior to filing of the
("pre-ipo placement"). The pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the brlms. If the pre-ipo placement is completed, the amount raised pursuant to the pre-ipo placement will be reduced from the fresh issue, subject to compliance with Rule 19(2)(b) of the securities contracts (Regulation) Rules, 1957, as amended. The pre-ipo placement, if undertaken, shall not exceed 20% of the size of the fresh issue. Prior to the completion of the offer, the company shall appropriately intimate the subscribers to the pre-ipo placement, prior to allotment pursuant to the pre-ipo placement, that there is no guarantee that the company may proceed with the offer or the offer may be successful and will result into listing of the equity shares on the stock exchanges. Further, relevant disclosures in relation to such intimation to the subscribers to the pre-ipo placement (if undertaken).
The face value of equity shares is Re. 1/- each. the offer price is [*] times the face value of the equity shares.
Price Band: 563 to 593 per equity share of face value of 1 each.
The floor price is 563 times the face value of the equity shares and the cap price is 593 times the face value of the equity shares.
Bids can be made for a minimum of 25 equity shares and in multiples of 25 equity shares thereafter. |
| Issue |
Money Payable On |
|
| Opens On |
Closes On |
Application |
Allotment |
|
| 21-Nov-25 |
25-Nov-25 |
Rs563.00-593.00 |
Rs0.00-0.00 |
| Minimum Application for shares in Nos :25 Further Multiples of :25 |
| |
RsCr |
Lead Managers to the Issue |
|
| Project Cost |
0.00 |
|
| Project Financed through Current Offer |
854.53 |
|
| Post Issue Equity Share Capital |
0.00 |
|
| Issue Price |
Rs563.00 |
|
|
|
|
| |
| Projects |
|
| Capital expenditure towards procurement of machinery for our production line located at Nandesari Facility I | General corporate purposes |
|
|
|
| Promoted By |
|
| Sujit Jaysukh Bhayani |
| Avani Sujit Bhayani |
| Shanil Sujit Bhayani |
|
|
| Registrar to the Issue |
|
| MUFG Intime India Pvt Ltd |
|
|
| |
|
|
|
|
|
| |
|
|
| |
| X |
| Filing complaints on SCORES |
| Easy & Quick |
| |
| › |
Register on SCORES Portal |
› |
Mandatory details for filing complaints on SCORES
| Name |
PAN |
Address |
Mobile No. |
Email ID |
|
| › |
Benefits: |
| |
|
|
|